KCS Wealth Advisory purchased a new stake in Danaher Co. (NYSE:DHR) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 6,968 shares of the conglomerate’s stock, valued at approximately $647,000.

A number of other institutional investors have also added to or reduced their stakes in DHR. JLB & Associates Inc. purchased a new position in shares of Danaher in the second quarter worth about $1,874,000. First Bank & Trust raised its stake in shares of Danaher by 3.1% in the second quarter. First Bank & Trust now owns 7,846 shares of the conglomerate’s stock worth $662,000 after purchasing an additional 234 shares during the last quarter. Beach Investment Management LLC. raised its stake in shares of Danaher by 1,013.8% in the second quarter. Beach Investment Management LLC. now owns 53,460 shares of the conglomerate’s stock worth $4,511,000 after purchasing an additional 48,660 shares during the last quarter. Cullen Frost Bankers Inc. raised its stake in shares of Danaher by 1.2% in the second quarter. Cullen Frost Bankers Inc. now owns 146,377 shares of the conglomerate’s stock worth $12,353,000 after purchasing an additional 1,716 shares during the last quarter. Finally, Honeywell International Inc. purchased a new position in shares of Danaher in the second quarter worth about $25,317,000. Institutional investors own 76.05% of the company’s stock.

Danaher Co. (DHR) traded up $0.80 during trading on Friday, reaching $99.39. The company had a trading volume of 1,875,557 shares, compared to its average volume of 2,300,000. The firm has a market capitalization of $69,140.00, a price-to-earnings ratio of 29.58, a price-to-earnings-growth ratio of 2.07 and a beta of 1.03. Danaher Co. has a 12-month low of $78.97 and a 12-month high of $99.66. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43.

Danaher (NYSE:DHR) last posted its earnings results on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, topping the consensus estimate of $0.95 by $0.05. The firm had revenue of $4.53 billion for the quarter, compared to analyst estimates of $4.47 billion. Danaher had a return on equity of 11.29% and a net margin of 13.36%. Danaher’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period last year, the company earned $0.87 earnings per share. sell-side analysts anticipate that Danaher Co. will post 3.99 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be issued a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a yield of 0.56%. The ex-dividend date of this dividend is Thursday, December 28th. Danaher’s dividend payout ratio (DPR) is 16.67%.

In related news, Director Donald J. Ehrlich sold 10,578 shares of the firm’s stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $90.82, for a total transaction of $960,693.96. Following the sale, the director now directly owns 104,621 shares of the company’s stock, valued at $9,501,679.22. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Daniel Raskas sold 37,870 shares of the firm’s stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $93.33, for a total value of $3,534,407.10. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 273,810 shares of company stock worth $25,218,813. 12.20% of the stock is owned by corporate insiders.

Several research analysts have recently issued reports on the company. Robert W. Baird restated a “buy” rating on shares of Danaher in a research note on Friday. Goldman Sachs Group restated a “neutral” rating and issued a $83.00 price objective on shares of Danaher in a research note on Tuesday, September 26th. Evercore ISI assumed coverage on Danaher in a research note on Wednesday, January 3rd. They issued an “outperform” rating for the company. Royal Bank of Canada restated a “hold” rating and issued a $96.00 price objective on shares of Danaher in a research note on Thursday, January 4th. Finally, Zacks Investment Research cut Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $94.91.

ILLEGAL ACTIVITY NOTICE: This article was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://www.watchlistnews.com/6968-shares-in-danaher-co-dhr-purchased-by-kcs-wealth-advisory/1804821.html.

Danaher Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.